Global insurance giant MetLife (NYSE: MET) met Wall Street’s revenue expectations in Q3 2026, with sales up 11.2% year on year to $19.91 billion. Its non-GAAP profit of $2.78 per share was in line with analysts’ consensus estimates.

Is now the time to buy MET? Find out in our full research report (it’s free for active Edge members).

StockStory’s take

MetLife’s latest quarter reflected steady execution across its global insurance and investment businesses, with results generally in line with Wall Street’s expectations and little movement in the share price. Key drivers included broad-based growth across operating segments, favorable variable investment income from private equity and venture capital, and disciplined expense control amid ongoing integration of PineBridge Investments. CEO Michel Khalaf emphasized the contribution of both capital-light and capital-driven earnings engines, noting, “No single business drove results. That breadth is the central strength of MetLife.”

Looking ahead, MetLife’s strategic guidance focuses on further leveraging technology, particularly artificial intelligence, to drive productivity and maintain expense discipline. Management highlighted an ongoing commitment to capital efficiency and selective growth investments, while cautioning that certain underwriting gains, such as favorable mortality trends, are expected to normalize over time. CFO John McCallion noted, “Our expense discipline, strong returns on new business, and improving capital efficiency are helping translate growth into higher returns and strong cash generation.”

Key insights from management’s remarks

Management attributed the quarter’s performance to broad-based growth, strong investment returns, and ongoing productivity initiatives, with no single segment outshining others.

• Variable investment income upside: Private equity and venture capital returns outperformed expectations, contributing substantially to earnings this quarter. Management noted that increased realizations and strong marks, especially in the venture capital portfolio, supported this outperformance but stressed the portfolio is designed for long-term stability rather than quarterly trading.
• Expense discipline through technology: Direct expense ratio improvement was driven by ongoing productivity efforts and the integration of artificial intelligence into operations. Management stated that AI is helping both with efficiency gains and enhancing customer experience, enabling MetLife to offset higher expenses from the PineBridge acquisition.
• Diversification of earnings sources: No single segment dominated results, with Group Benefits leading on underwriting margins, Retirement and Income Solutions (RIS) and Asia contributing to investment gains, and Latin America and EMEA driving top-line growth. This diversified approach is designed to provide resilience across market cycles.
• Capital deployment efficiency: MetLife reported improved returns on new business, with a higher internal rate of return (IRR) and shorter payback periods on deployed capital compared to prior years. Management emphasized that capital is allocated only when it meets strict return standards, leading to higher value creation per dollar invested.
• Expansion in embedded and digital insurance: The company is scaling its embedded insurance offerings and leveraging digital partnerships, such as the new collaboration with Revolut in Europe, to extend reach and improve customer experience across multiple regions.

Drivers of future performance

Management’s outlook centers on sustained growth, continued cost discipline, and balancing capital deployment between organic expansion and shareholder returns.

• Technology-driven productivity gains: Ongoing investments in artificial intelligence and digital platforms are expected to drive both operational efficiency and revenue growth, with management signaling that technology will be a key lever for maintaining a competitive expense ratio.
• Normalization of underwriting trends: Recent favorable mortality and disability trends are expected to gradually return to more typical levels, with pricing adjustments and proactive risk management helping mitigate margin compression over the next several years.
• Disciplined capital allocation: The company plans to prioritize organic growth opportunities that meet strict return hurdles, while remaining open to selective acquisitions in asset management or group insurance. Free cash flow generation is expected to remain strong, supporting continued buybacks and dividends without compromising financial flexibility.

Catalysts in upcoming quarters

In the coming quarters, our analysts will watch (1) signs of sustained expense ratio improvement as AI and digital initiatives scale, (2) ongoing diversification and profitability of MetLife’s global insurance and investment businesses, and (3) continued execution on capital deployment through both organic growth and selective acquisitions. The pace of normalization in underwriting margins and momentum in digital partnerships like Revolut will also be key areas of focus.

MetLife currently trades at $102.94, in line with $102.89 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).

Now could be the perfect time to invest in these stocks

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Exlservice (+271% between June 2020 and June 2025). Find your next big winner with StockStory today.